Standout Papers

Efficacy of everolimus in advanced renal cell carcinoma: a d... 1998 2026 2007 2016 2.3k
  1. Efficacy of everolimus in advanced renal cell carcinoma: a double-blind, randomised, placebo-controlled phase III trial (2008)
    Robert J. Motzer, Bernard Escudier et al. The Lancet
  2. Bevacizumab plus interferon alfa-2a for treatment of metastatic renal cell carcinoma: a randomised, double-blind phase III trial (2007)
    Bernard Escudier, A Płużańska et al. The Lancet
  3. Phase 3 trial of everolimus for metastatic renal cell carcinoma (2010)
    Robert J. Motzer, Bernard Escudier et al. Cancer
  4. Recombinant Human Interleukin-2, Recombinant Human Interferon Alfa-2a, or Both in Metastatic Renal-Cell Carcinoma (1998)
    Sylvie Négrier, Bernard Escudier et al. New England Journal of Medicine
  5. Phase III Trial of Bevacizumab Plus Interferon Alfa-2a in Patients With Metastatic Renal Cell Carcinoma (AVOREN): Final Analysis of Overall Survival (2010)
    Bernard Escudier, Joaquim Bellmunt et al. Journal of Clinical Oncology
  6. Avelumab, an Anti–Programmed Death-Ligand 1 Antibody, In Patients With Refractory Metastatic Urothelial Carcinoma: Results From a Multicenter, Phase Ib Study (2017)
    Andrea B. Apolo, Jeffrey R. Infante et al. Journal of Clinical Oncology
  7. Avelumab in metastatic urothelial carcinoma after platinum failure (JAVELIN Solid Tumor): pooled results from two expansion cohorts of an open-label, phase 1 trial (2017)
    Manish R. Patel, John Ellerton et al. The Lancet Oncology
  8. Bladder cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up (2021)
    Tom Powles, Joaquim Bellmunt et al. Annals of Oncology
  9. ESMO Clinical Practice Guideline interim update on first-line therapy in advanced urothelial carcinoma (2024)
    Thomas Powles, Joaquim Bellmunt et al. Annals of Oncology

Immediate Impact

10 by Nobel laureates 3 from Science/Nature 158 standout
Sub-graph 1 of 15

Citing Papers

Renal cell carcinoma
2024 Standout
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries
2021 Standout
48 intermediate papers

Works of Alain Ravaud being referenced

Lapatinib Versus Hormone Therapy in Patients With Advanced Renal Cell Carcinoma: A Randomized Phase III Clinical Trial
2008
Midterm Local Efficacy and Survival after Radiofrequency Ablation of Lung Tumors with Minimum Follow-up of 1 Year: Prospective Evaluation
2006
and 29 more

Author Peers

Author Last Decade Papers Cites
Alain Ravaud 10175 6677 7878 366 17.4k
Georg A. Bjarnason 7795 4391 6569 273 13.5k
Sandro Barni 4211 7509 1870 476 14.1k
Aung Naing 2918 5706 4345 477 12.1k
Nizar M. Tannir 7553 4566 5847 485 12.4k
Sumanta K. Pal 8419 7729 6717 724 16.8k
Stefan Sleijfer 4582 6993 4150 378 13.2k
Christopher J. Logothetis 9469 7820 6778 448 20.4k
Christine Marosi 5483 4415 7088 193 23.8k
Tae Min Kim 5370 7417 3171 450 12.9k
Manisha H. Shah 3243 7500 4162 198 17.4k

All Works

Loading papers...

Rankless by CCL
2026